4D MOLECULAR THERAPEUTICS IN (FDMT) Top Institutional Shareholders
4D MOLECULAR THERAPEUTICS IN (FDMT) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $437.61M in FDMT holdings during the latest filing period.
Janus Henderson Group Plc is currently the largest disclosed institutional shareholder of FDMT tracked by InsiderSet, reporting ownership valued at approximately $48.87M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $49.43M, representing an estimated gain of +1.15% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 70% of the total disclosed FDMT value among the investors covered in this analysis. Major shareholders include Janus Henderson Group Plc, Ra Capital Management, L.P., Goldman Sachs Group Inc, and several other long-term asset managers with concentrated positions in 4D MOLECULAR THERAPEUTICS IN (FDMT).
This page ranks the largest institutional FDMT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
143
Total Reported Value
$437.61M
Largest Holder
Janus Henderson Group Plc
Largest Position
$48.87M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
174
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Plc | 0.02% | 5,247,151 | $48,868,164 | $49,428,162 | +$559,998 | +1.15% | |
| Ra Capital Management, L.P. | 0.50% | 5,049,779 | $47,013,442 | $47,568,918 | +$555,476 | +1.18% | |
| Goldman Sachs Group Inc | 0.01% | 4,205,438 | $39,152,628 | $39,615,226 | +$462,598 | +1.18% | |
| Blackrock, Inc. | 0.00% | 4,145,303 | $38,592,771 | $39,048,754 | +$455,983 | +1.18% | |
| Novo Holdings A/S | 2.75% | 3,650,737 | $33,988,361 | $34,389,943 | +$401,582 | +1.18% | |
| Bvf Inc/Il | 0.85% | 2,879,289 | $26,806,181 | $27,122,902 | +$316,721 | +1.18% | |
| State Street Corp | 0.00% | 2,707,875 | $25,210,316 | $25,508,183 | +$297,867 | +1.18% | |
| Armistice Capital, Llc | 0.61% | 2,000,000 | $18,620,000 | $18,840,000 | +$220,000 | +1.18% | |
| Adage Capital Partners Gp, L.L.C. | 0.02% | 1,605,156 | $14,944,002 | $15,120,570 | +$176,568 | +1.18% | |
| Federated Hermes, Inc. | 0.02% | 1,432,260 | $13,334,340 | $13,491,889 | +$157,549 | +1.18% | |
| Trails Edge Capital Partners, Lp | 2.85% | 1,302,917 | $12,130,157 | $12,273,478 | +$143,321 | +1.18% | |
| Geode Capital Management, Llc | 0.00% | 1,065,345 | $9,921,110 | $10,035,550 | +$114,440 | +1.15% | |
| Bank Of America Corp | 0.00% | 974,173 | $9,069,551 | $9,176,710 | +$107,159 | +1.18% | |
| Evergreen Quality Fund Gp, Ltd. | 0.20% | 951,474 | $8,858,223 | $8,962,885 | +$104,662 | +1.18% | |
| Deutsche Bank Ag\ | 0.00% | 708,044 | $6,591,890 | $6,669,774 | +$77,884 | +1.18% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 578,265 | $5,383,647 | $5,447,256 | +$63,609 | +1.18% |
| Nuveen, Llc | 0.00% | 561,805 | $5,230,404 | $5,292,203 | +$61,799 | +1.18% | |
| Parkman Healthcare Partners Llc | 0.50% | 522,577 | $4,865,192 | $4,922,675 | +$57,483 | +1.18% | |
| Dimensional Fund Advisors Lp | 0.00% | 522,823 | $4,862,901 | $4,924,993 | +$62,092 | +1.28% | |
| Rtw Investments, Lp | 0.04% | 475,737 | $4,429,111 | $4,481,443 | +$52,332 | +1.18% | |
| Propel Bio Management, Llc | 2.26% | 380,420 | $3,581,151 | $3,583,556 | +$2,405 | +0.07% | |
| Morgan Stanley | 0.00% | 345,410 | $3,215,767 | $3,253,762 | +$37,995 | +1.18% | |
| Northern Trust Corp | 0.00% | 342,034 | $3,184,337 | $3,221,960 | +$37,623 | +1.18% | |
| Charles Schwab Investment Management Inc | 0.00% | 328,379 | $3,057,208 | $3,093,330 | +$36,122 | +1.18% | |
| Invesco Ltd. | 0.00% | 310,684 | $2,892,468 | $2,926,643 | +$34,175 | +1.18% | |
| Burkehill Global Management, Lp | 0.13% | 275,000 | $2,560,250 | $2,590,500 | +$30,250 | +1.18% | |
| Raymond James Financial Inc | 0.00% | 266,147 | $2,477,829 | $2,507,105 | +$29,276 | +1.18% | |
| Citadel Advisors Llc | 0.00% | 264,096 | $2,458,733 | $2,487,784 | +$29,051 | +1.18% | |
| Peapod Lane Capital Llc | 1.81% | 241,480 | $2,209,564 | $2,274,742 | +$65,178 | +2.95% | |
| Arrowmark Colorado Holdings Llc | 0.05% | 202,864 | $1,888,664 | $1,910,979 | +$22,315 | +1.18% | |
| Woodline Partners Lp | 0.01% | 200,001 | $1,862,009 | $1,884,009 | +$22,000 | +1.18% | |
| Privium Fund Management B.V. | 0.33% | 170,256 | $1,585,083 | $1,603,812 | +$18,729 | +1.18% | |
| Ubs Group Ag | 0.00% | 158,120 | $1,472,097 | $1,489,490 | +$17,393 | +1.18% | |
| Perigon Wealth Management, Llc | 0.02% | 146,197 | $1,361,094 | $1,377,176 | +$16,082 | +1.18% | |
| Bank Of New York Mellon Corp | 0.00% | 133,607 | $1,243,877 | $1,258,578 | +$14,701 | +1.18% | |
| Exome Asset Management Llc | 0.72% | 130,564 | $1,215,551 | $1,229,913 | +$14,362 | +1.18% | |
| Two Sigma Investments, Lp | 0.00% | 124,317 | $1,157,391 | $1,171,066 | +$13,675 | +1.18% | |
| Susquehanna International Group, Llp | 0.00% | 124,228 | $1,156,563 | $1,170,228 | +$13,665 | +1.18% | |
| Adar1 Capital Management, Llc | 0.07% | 116,712 | $1,086,589 | $1,099,427 | +$12,838 | +1.18% | |
| Opaleye Management Inc. | 0.14% | 112,291 | $1,045,429 | $1,057,781 | +$12,352 | +1.18% | |
| Wellington Management Group Llp | 0.00% | 108,872 | $1,013,599 | $1,025,574 | +$11,975 | +1.18% | |
| American Century Companies Inc | 0.00% | 101,511 | $945,067 | $956,234 | +$11,167 | +1.18% | |
| Schonfeld Strategic Advisors Llc | 0.01% | 101,110 | $941,332 | $952,456 | +$11,124 | +1.18% | |
| Xtx Topco Ltd | 0.01% | 83,405 | $776,501 | $785,675 | +$9,174 | +1.18% | |
| Assenagon Asset Management S.A. | 0.00% | 83,333 | $775,830 | $784,997 | +$9,167 | +1.18% | |
| Rafferty Asset Management, Llc | 0.00% | 71,396 | $664,697 | $672,550 | +$7,853 | +1.18% | |
| Simplify Asset Management Inc. | 0.01% | 70,430 | $655,703 | $663,451 | +$7,748 | +1.18% | |
| Fmr Llc | 0.00% | 70,097 | $652,598 | $660,314 | +$7,716 | +1.18% | |
| Squarepoint Ops Llc | 0.00% | 62,513 | $581,996 | $588,872 | +$6,876 | +1.18% | |
| Rhumbline Advisers | 0.00% | 54,101 | $503,671 | $509,631 | +$5,960 | +1.18% |
Frequently asked questions about FDMT
Who owns the most FDMT stock?
The largest holders of FDMT are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for 4D MOLECULAR THERAPEUTICS IN (FDMT).
Is FDMT widely held by superinvestors?
Many widely followed stocks like FDMT appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly FDMT is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.